Go Back   HER2 Support Group Forums > Articles of Interest
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

Thread Tools Display Modes
Old 06-17-2003, 02:36 AM   #1
Posts: n/a
A new early phase study at UCLA's Jonsson Cancer Center for the first time pairs two molecularly targeted drugs as a one-two punch to fight metastatic breast cancer. The drugs attack only the cancer and the blood vessel cells and leave the healthy cells unharmed.

Jonsson Cancer Center researchers are seeking volunteers with untreated HER-2/neu positive advanced breast cancer to participate in the research which does not use chemotherapy or other conventional treatments. The study combines the monoclonal antibody Herceptin with the experimental angiogenesis inhibitor Avastin which current studies indicate may extend the lives of patients with advanced colorectal cancer.

For more information contact UCLA at 310-825-8375
  Reply With Quote

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On

Forum Jump

All times are GMT -7. The time now is 05:49 PM.

Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2020, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007
free webpage hit counter